Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 52, Issue 24, Pages 7962-7965Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm901434t
Keywords
-
Categories
Ask authors/readers for more resources
A series of 3-aryl-4-isoxazolecarboxamides identified from a high-throughput screening campaign as novel, potent small molecule agonists of the human TGR5 G-protein coupled receptor is described. Subsequent optimization resulted in the rapid identification of potent exemplars 6 and 7 which demonstrated improved GLP-1 secretion in vivo via an intracolonic dose coadministered with glucose challenge in a canine model. These novel TGR5 receptor agonists are potentially useful therapeutics for metabolic disorders such as type II diabetes and its associated complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available